iBio, Inc. Annual Operating Income (Loss) in USD from 2011 to 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
iBio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2023.
- iBio, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$3.63M, a 41.2% increase year-over-year.
- iBio, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$18.2M, a 47.8% increase year-over-year.
- iBio, Inc. annual Operating Income (Loss) for 2023 was -$29.3M, a 1.19% increase from 2022.
- iBio, Inc. annual Operating Income (Loss) for 2022 was -$29.7M, a 4.55% increase from 2021.
- iBio, Inc. annual Operating Income (Loss) for 2021 was -$31.1M, a 122% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)